Clearbridge Gains FDA Registration for ClearCell FX1 System
Jan 9, 2018 @ 8:02

The company plans to continue to validate the liquid biopsy system for use in cancer diagnostics, therapy management, and patient monitoring.

Sourced through Scoop.it from: www.genomeweb.com

Leave a Reply